NVE Corp banner

NVE Corp
NASDAQ:NVEC

Watchlist Manager
NVE Corp Logo
NVE Corp
NASDAQ:NVEC
Watchlist
Price: 66.57 USD 1%
Market Cap: $322.2m

NVE Corp
Investor Relations

NVE Corp. engages in the development and sale of devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company is headquartered in Eden Prairie, Minnesota and currently employs 44 full-time employees. The firm manufactures spintronic products, including sensors and couplers that are used to acquire and transmit data. The firm has also licensed its spintronic magnetoresistive random access memory technology (MRAM). Its parts are found Industrial, scientific, and medical applications, as well as the Industrial Internet of Things. The firm's products include sensor, coupler, and MRAM product. Its sensor products detect the strength or gradient of magnetic fields and are often used to determine position or speed. Its spintronic couplers combine a giant magnetoresistance (GMR) sensor element and a microscopic coil. MRAM uses spintronics to store data. The company combines the speed of static random-access memory (SRAM), the density of dynamic random-access memory (DRAM) and the nonvolatility of flash memory.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Jan 21, 2026
AI Summary
Q3 2026

Revenue Growth: NVE reported a 23% year-over-year revenue increase for the third quarter, driven by broad-based growth across product lines and channels.

Earnings Up: Net income rose 11% to $3.38 million, or $0.70 per diluted share, benefiting from higher revenue and lower operating expenses.

Gross Margin Decline: Gross margin fell to 79% from 84% last year, due to a less profitable product mix and increased distributor sales.

Lower Expenses: Operating expenses dropped 12%, with R&D down 9% and SG&A down 19% from the prior year.

Outlook: Management voiced optimism about continued growth, improved distributor inventory levels, and future sales from recent R&D and new equipment investments.

Abbott Agreement: NVE extended a supply partnership with Abbott Laboratories for two years, including price increases through 2027.

New Capacity & Products: Installation of new production equipment is on schedule and expected to enhance capacity, miniaturization, and sales opportunities.

Key Financials
Revenue
$8.38 million
Net Income
$3.38 million
Diluted EPS
$0.70
Gross Margin
79%
Operating Margin
60%
Pretax Margin
68%
Net Margin
54%
Effective Tax Rate
20%
Cash Flow from Operations
$12.2 million
Fixed Asset Purchases
$2.18 million (first 9 months)
Earnings Call Recording
Other Earnings Calls

Management

Dr. Daniel A. Baker Ph.D.
CEO, President & Director
No Bio Available
Mr. Daniel Nelson
Accounting Manager & Principal Financial Officer
No Bio Available
Dr. Peter G. Eames Ph.D.
Vice President of Advanced Technology
No Bio Available
Mr. John K. Myers
Vice President of New Business Development
No Bio Available

Contacts

Address
MINNESOTA
Eden Prairie
11409 Valley View Road
Contacts
+19528299217.0
www.nve.com